Real-World Experience and Laboratory Monitoring of Dupilumab in Patients with Moderate to Severe Atopic Dermatitis in a Tertiary Centre. (2021)
Attributed to:
MICA: The North West England MRC Fellowship Scheme in Clinical Pharmacology and Therapeutics
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s13555-020-00469-6
PubMed Identifier: 33315229
Publication URI: http://europepmc.org/abstract/MED/33315229
Type: Journal Article/Review
Volume: 11
Parent Publication: Dermatology and therapy
Issue: 1